サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1641742

薬物乱用検査の世界市場：製品・サービス別、サンプルタイプ別、エンドユーザー別 - 機会分析と産業予測（2024年～2033年）

Drug Abuse Testing Market By Product and Service , By Sample type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
薬物乱用検査の世界市場：製品・サービス別、サンプルタイプ別、エンドユーザー別 - 機会分析と産業予測（2024年～2033年）
出版日: 2024年12月01日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の薬物乱用検査の市場規模は、2023年に500万米ドルと評価され、2024年～2033年にCAGR6%で成長し、2033年には880万米ドルに達すると予測されています。

Drug Abuse Testing Market-IMG1

薬物乱用検査とは、人の体内における違法薬物、処方薬、またはそれらの代謝物の存在を特定する科学的プロセスを指します。この検査は、尿、血液、唾液、毛髪、汗などの生物学的検体を用いて実施され、個人が特定の物質を使用したかどうかを判定します。薬物乱用検査は、職場の安全、臨床診断、法的調査、リハビリテーション・プログラムにおいて重要なツールです。

世界の薬物乱用障害の憂慮すべき増加は、薬物乱用検査市場の主な促進要因です。国連薬物犯罪事務所（UNODC）の報告書によると、2022年には15～64歳の2億8,400万人以上が少なくとも一度は薬物を使用しており、広範な検査の必要性が浮き彫りになっています。さらに、飲酒運転や薬物関連犯罪など、薬物乱用が治安に与える影響に対する意識の高まりが、法執行機関や交通監視プログラムにおける定期的な薬物検査の需要を押し上げています。さらに、世界の薬物入手可能性の増加が市場成長に大きく寄与しています。例えば、European Monitoring Centre for Drugs and Drug Addiction（EMCDDA）は2024年に、欧州では様々な薬物がかつてないほど入手しやすくなっており、大麻が最も一般的に使用されている違法薬物であり、コカインがそれに続いていると報告しています。さらに、費用対効果が高く使いやすい家庭用薬物検査キットが入手可能になったことで、個人や家庭での採用が増加し、市場拡大に寄与しています。しかし、液体クロマトグラフィー質量分析法などの高度な薬物検査技術は高価です。そのため、特に資源に制約のあるヘルスケア環境では、導入が制限される可能性があります。社会的な判断や差別を恐れるあまり、個人が自発的に薬物検査を受けることを躊躇し、検査プログラムの成長にさらに影響を及ぼす可能性もあります。それとは逆に、ポイント・オブ・ケア検査機器、改良型免疫測定法、質量分析技術などの技術革新により、薬物検査の正確性、迅速性、利用しやすさが向上しています。このような開発は、予測期間中の世界市場拡大に有益な機会を提供すると期待されます。

薬物乱用検査市場は、製品・サービス、サンプルタイプ、エンドユーザー、地域に区分されます。製品・サービス別では、市場は分析装置、迅速検査装置、消耗品、ラボサービスに分けられます。分析装置はさらに免疫測定分析装置、クロマトグラフィー分析装置、呼気分析装置に区分されます。迅速検査装置は尿検査装置と口腔液検査装置に細分されます。消耗品セグメントはさらに、アッセイキット、サンプル採取カップ、キャリブレーター・コントロール、その他に分類されます。サンプルタイプ別では、尿、口腔液、呼気、毛髪、その他のサンプルに分類されます。エンドユーザー別では、職場・学校、刑事司法システム・法執行機関、研究室、病院に細分化されます。地域別では、北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカで分析されます。

主な調査結果

製品・サービス別では、分析装置が2023年の市場シェアを占めました。

サンプルタイプ別では、尿セグメントが2023年に最も高い成長を示しました。

エンドユーザー別では、職場・学校セグメントが2023年に最大シェアを獲得しました。

地域別では、北米が2023年に最大の市場シェアを占め、予測期間中に高いペースで成長すると予測されています。

本レポートで可能なレポートカスタマイズ（追加費用とタイムラインに関しましては販売担当へご連絡ください）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析：市場規模と予測
  • 平均販売価格分析/プライスポイント分析
  • クリスクロスセグメント分析：市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要企業の詳細（所在地、連絡先詳細、サプライヤー/ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 薬物乱用検査市場：製品・サービス別

  • 市場概要
  • 分析装置
    • 免疫測定分析装置
    • クロマトグラフィー分析装置
    • 呼気分析装置
  • 迅速検査装置
    • 尿検査装置
    • 口腔液検査装置
  • 消耗品
    • アッセイキット
    • サンプル採取カップ
    • キャリブレーター・コントロール
    • その他
  • ラボサービス

第5章 薬物乱用検査市場：サンプルタイプ別

  • 市場概要
  • 尿
  • 口腔液
  • 呼気
  • 毛髪
  • その他のサンプル

第6章 薬物乱用検査市場：エンドユーザー別

  • 市場概要
  • 職場・学校
  • 刑事司法システム・法執行機関
  • 研究室
  • 病院

第7章 薬物乱用検査市場：地域別

  • 市場概要
  • 北米
    • 主な市場動向と機会
    • 米国の薬物乱用検査市場
    • カナダの薬物乱用検査市場
    • メキシコの薬物乱用検査市場
  • 欧州
    • 主要市場動向と機会
    • フランスの薬物乱用検査市場
    • ドイツの薬物乱用検査市場
    • イタリアの薬物乱用検査市場
    • スペインの薬物乱用検査市場
    • 英国の薬物乱用検査市場
    • その他欧州の薬物乱用検査市場
  • アジア太平洋
    • 主な市場動向と機会
    • 中国の薬物乱用検査市場
    • 日本の薬物乱用検査市場
    • インドの薬物乱用検査市場
    • 韓国の薬物乱用検査市場
    • オーストラリアの薬物乱用検査市場
    • その他アジア太平洋の薬物乱用検査市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの薬物乱用検査市場
    • 南アフリカの薬物乱用検査市場
    • サウジアラビアの薬物乱用検査市場
    • その他ラテンアメリカ・中東・アフリカの薬物乱用検査市場

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10企業の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング：2023年

第9章 企業プロファイル

  • The Dragerwerk AG And Co. KGaA
  • Abbott Laboratories
  • F. HOFFMANN-LA ROCHE AG
  • Bio Rad Laboratories, Inc.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • Laboratory Corporation Of America Holdings
  • Danaher Corporation
  • Quest Diagnostics Incorporated
  • Express Diagnostics International Inc.
目次
Product Code: A00035

The drug abuse testing market was valued at $5.0 million in 2023, and is projected to reach $8.8 million by 2033, growing at a CAGR of 6% from 2024 to 2033.

Drug Abuse Testing Market - IMG1

Drug abuse testing refers to the scientific process of identifying the presence of illicit drugs, prescription medications, or their metabolites in a person's system. This testing is conducted using biological specimens such as urine, blood, saliva, hair, or sweat to determine if an individual has used specific substances. Drug abuse testing is a critical tool in workplace safety, clinical diagnostics, legal investigations, and rehabilitation programs.

Alarming increase in prevalence of substance abuse disorders worldwide is a primary driver of the drug abuse testing market. According to a report by the United Nations Office on Drugs and Crime (UNODC), over 284 million people aged 15-64 used drugs at least once in 2022, underscoring the need for widespread testing. In addition, rise in awareness about the impact of substance abuse on public safety, such as impaired driving and drug-related crimes, has driven the demand for routine drug testing in law enforcement and traffic monitoring programs. Moreover, increase in global drug availability significantly contributes toward the market growth. For instance, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) reported in 2024 that Europe is experiencing unprecedented availability of various drugs, with cannabis being the most commonly used illicit drug, followed by cocaine. Furthermore, the availability of cost-effective and easy-to-use home drug testing kits has seen increased adoption among individuals and families, contributing to market expansion. However, sophisticated drug testing techniques, such as liquid chromatography-mass spectrometry, are expensive. This can limit their adoption, especially in resource-constrained healthcare settings. Fear of societal judgment and discrimination may deter individuals from undergoing drug testing voluntarily, further affecting the growth of testing programs. On the contrary, technological innovations, such as point-of-care testing devices, improved immunoassays, and mass spectrometry techniques, have made drug testing more accurate, faster, and accessible. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The drug abuse testing market is segmented into product & service, sample type, end user, and region. By product & service, the market is divided into analyzers, rapid testing devices, consumables and laboratory services. The analyzers segment is further segmented into immunoassay analyzers, chromatography analyzers and breath analyzers. The rapid testing devices is subdivided into urine testing devices and oral fluid testing devices. The consumables segment is further categorized into assay kits, sample collection cups, calibrators & controls, and others. Depending on sample type, the market is segregated into urine, oral fluid, breath, hair, and other samples. By end user, it is fragmented into workplaces & schools, criminal justice systems & law enforcement agencies, research laboratories, and hospitals. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product & service, the analyzers segment dominated the market share in 2023.

On the basis of sample type, the urine segment exhibit the highest growth in 2023.

Depending on end user segment, the workplaces & schools segment garnered the largest share in 2023.

Region wise, North America held the largest market share in 2023, and is projected to grow at a high pace during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global drug abuse testing market include The Dragerwerk AG & Co. KGaA, Abbott Laboratories, F. HOFFMANN-LA ROCHE AG, Bio Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Danaher Corporation, Quest Diagnostics Incorporated, and Express Diagnostics International Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product And Service

  • Analyzers
    • Immunoassay analyzers
    • Chromatography analyzers
    • Breath analyzers
  • Rapid Testing Devices
    • Urine testing devices
    • Oral fluid testing devices
  • Consumables
    • Assay kits
    • Sample collection cups
    • Calibrators and controls
    • Others
  • Laboratory Services

By Sample Type

  • Urine
  • Oral Fluid
  • Breath
  • Hair
  • Other Samples

By End User

  • Workplaces and Schools
  • Criminal Justice Systems and Law Enforcement Agencies
  • Research laboratories
  • Hospitals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • The Dragerwerk AG & Co. KGaA
    • Abbott Laboratories
    • F. HOFFMANN-LA ROCHE AG
    • Bio Rad Laboratories, Inc.
    • Siemens AG
    • Thermo Fisher Scientific, Inc.
    • Laboratory Corporation of America Holdings
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Express Diagnostics International Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: DRUG ABUSE TESTING MARKET, BY PRODUCT AND SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product And Service
  • 4.2. Analyzers
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.5. Immunoassay analyzers
      • 4.2.5.1. Market Size and Forecast
    • 4.2.6. Chromatography analyzers
      • 4.2.6.1. Market Size and Forecast
    • 4.2.7. Breath analyzers
      • 4.2.7.1. Market Size and Forecast
  • 4.3. Rapid Testing Devices
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
    • 4.3.5. Urine testing devices
      • 4.3.5.1. Market Size and Forecast
    • 4.3.6. Oral fluid testing devices
      • 4.3.6.1. Market Size and Forecast
  • 4.4. Consumables
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
    • 4.4.5. Assay kits
      • 4.4.5.1. Market Size and Forecast
    • 4.4.6. Sample collection cups
      • 4.4.6.1. Market Size and Forecast
    • 4.4.7. Calibrators and controls
      • 4.4.7.1. Market Size and Forecast
    • 4.4.8. Others
      • 4.4.8.1. Market Size and Forecast
  • 4.5. Laboratory Services
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: DRUG ABUSE TESTING MARKET, BY SAMPLE TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Sample Type
  • 5.2. Urine
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Oral Fluid
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Breath
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Hair
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Other Samples
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: DRUG ABUSE TESTING MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Workplaces And Schools
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Criminal Justice Systems And Law Enforcement Agencies
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Research Laboratories
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Hospitals
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: DRUG ABUSE TESTING MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product And Service
    • 7.2.3. Market Size and Forecast, By Sample Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Drug Abuse Testing Market
      • 7.2.6.1. Market Size and Forecast, By Product And Service
      • 7.2.6.2. Market Size and Forecast, By Sample Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Drug Abuse Testing Market
      • 7.2.7.1. Market Size and Forecast, By Product And Service
      • 7.2.7.2. Market Size and Forecast, By Sample Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Drug Abuse Testing Market
      • 7.2.8.1. Market Size and Forecast, By Product And Service
      • 7.2.8.2. Market Size and Forecast, By Sample Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product And Service
    • 7.3.3. Market Size and Forecast, By Sample Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Drug Abuse Testing Market
      • 7.3.6.1. Market Size and Forecast, By Product And Service
      • 7.3.6.2. Market Size and Forecast, By Sample Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Drug Abuse Testing Market
      • 7.3.7.1. Market Size and Forecast, By Product And Service
      • 7.3.7.2. Market Size and Forecast, By Sample Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Drug Abuse Testing Market
      • 7.3.8.1. Market Size and Forecast, By Product And Service
      • 7.3.8.2. Market Size and Forecast, By Sample Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Drug Abuse Testing Market
      • 7.3.9.1. Market Size and Forecast, By Product And Service
      • 7.3.9.2. Market Size and Forecast, By Sample Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Drug Abuse Testing Market
      • 7.3.10.1. Market Size and Forecast, By Product And Service
      • 7.3.10.2. Market Size and Forecast, By Sample Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Drug Abuse Testing Market
      • 7.3.11.1. Market Size and Forecast, By Product And Service
      • 7.3.11.2. Market Size and Forecast, By Sample Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product And Service
    • 7.4.3. Market Size and Forecast, By Sample Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Drug Abuse Testing Market
      • 7.4.6.1. Market Size and Forecast, By Product And Service
      • 7.4.6.2. Market Size and Forecast, By Sample Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Drug Abuse Testing Market
      • 7.4.7.1. Market Size and Forecast, By Product And Service
      • 7.4.7.2. Market Size and Forecast, By Sample Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Drug Abuse Testing Market
      • 7.4.8.1. Market Size and Forecast, By Product And Service
      • 7.4.8.2. Market Size and Forecast, By Sample Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Drug Abuse Testing Market
      • 7.4.9.1. Market Size and Forecast, By Product And Service
      • 7.4.9.2. Market Size and Forecast, By Sample Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Drug Abuse Testing Market
      • 7.4.10.1. Market Size and Forecast, By Product And Service
      • 7.4.10.2. Market Size and Forecast, By Sample Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Drug Abuse Testing Market
      • 7.4.11.1. Market Size and Forecast, By Product And Service
      • 7.4.11.2. Market Size and Forecast, By Sample Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product And Service
    • 7.5.3. Market Size and Forecast, By Sample Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Drug Abuse Testing Market
      • 7.5.6.1. Market Size and Forecast, By Product And Service
      • 7.5.6.2. Market Size and Forecast, By Sample Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Drug Abuse Testing Market
      • 7.5.7.1. Market Size and Forecast, By Product And Service
      • 7.5.7.2. Market Size and Forecast, By Sample Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Drug Abuse Testing Market
      • 7.5.8.1. Market Size and Forecast, By Product And Service
      • 7.5.8.2. Market Size and Forecast, By Sample Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Drug Abuse Testing Market
      • 7.5.9.1. Market Size and Forecast, By Product And Service
      • 7.5.9.2. Market Size and Forecast, By Sample Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. The Dragerwerk AG And Co. KGaA
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Abbott Laboratories
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. F. HOFFMANN-LA ROCHE AG
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Bio Rad Laboratories, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Siemens AG
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Thermo Fisher Scientific, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Laboratory Corporation Of America Holdings
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Danaher Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Quest Diagnostics Incorporated
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Express Diagnostics International Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments